Page last updated: 2024-11-12

dragmacidin d

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

dragmacidin D: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15000037
CHEMBL ID513753
SCHEMBL ID19236248
MeSH IDM0444773

Synonyms (4)

Synonym
dragmacidin d
CHEMBL513753
SCHEMBL19236248
6-[4-[1-(2-amino-2,3-dihydro-1h-imidazol-4-yl)ethyl]-7-hydroxy-1h-indol-3-yl]-3-(6-bromo-1h-indol-3-yl)-1h-pyrazin-2-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID401044Antifungal activity against Candida albicans1998Journal of natural products, May, Volume: 61, Issue:5
Dragmacidins: new protein phosphatase inhibitors from a southern australian deep-water marine sponge, spongosorites sp
AID401041Antibacterial activity against Escherichia coli1998Journal of natural products, May, Volume: 61, Issue:5
Dragmacidins: new protein phosphatase inhibitors from a southern australian deep-water marine sponge, spongosorites sp
AID401042Inhibition of PP11998Journal of natural products, May, Volume: 61, Issue:5
Dragmacidins: new protein phosphatase inhibitors from a southern australian deep-water marine sponge, spongosorites sp
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]